Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis

Nguyen, HV; Vandenberg, CJ; Ng, AP; Robati, MR; Anstee, NS; Rimes, J; Hawkins, ED; Cory, S

Cory, S (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.

BLOOD, 2020; 135 (13): 1019